EUVIMEDEUVIMED entdecken
Crossref

Diffuse Cyclin D1 and SPINK1 Expression in Gastric Oxyntic Gland Neoplasms: Promising Diagnostic Markers Identified Using Spatial Transcriptome Analysis

Aya Shinozaki-Ushiku, Daizo Koinuma, Atsuhito Nakayama, Junichi Nawa, Mitsuhiro Fujishiro, Tetsuo Ushiku

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Aya Shinozaki-Ushiku und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Integrative Genomics, Graduate School of M…. Hauptthemen laut MEDLINE: Trypsin Inhibitor, Kazal Pancreatic, Cyclin D1, Biomarkers, Tumor, Stomach Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxyntic gland neoplasms typically arise in Helicobacter pylori-naive stomachs and are composed predominantly of chief cells, with a smaller component of parietal cells. Their pathologic diagnosis can be challenging owing to minimal cellular atypia. Especially in biopsy specimens with a limited tumor volume or when pathologists have limited experience in diagnosing this neoplasm, distinguishing them from normal oxyntic glands can be difficult, and no reliable diagnostic markers are currently available. In this study, single-cell spatial transcriptome analysis successfully identified significant upregulation of CCND1 and SPINK1 in all 6 analyzed cases of oxyntic gland neoplasms compared with normal oxyntic glands. Immunohistochemical analysis confirmed this finding in 21 endoscopically resected cases of oxyntic gland neoplasms, demonstrating that cyclin D1 and serine peptidase inhibitor Kazal type 1 (SPINK1) were diffusely expressed in oxyntic gland neoplasms, whereas their expression was scarcely observed in normal oxyntic glands, with a few of them showing weak to moderate staining. Even in biopsy specimens, these 2 markers highlighted the tumor areas and clearly distinguished neoplastic from normal oxyntic glands. Nonneoplastic foveolar epithelia and mucous neck cells also showed positive staining for both cyclin D1 and SPINK1. In addition, a mild increase in cyclin D1 expression and patchy or mosaic expression of SPINK1 were observed in fundic gland polyps, H. pylori-associated gastritis, and pyloric gland adenomas, whereas a diffuse staining pattern was specific to oxyntic gland neoplasms. These observations suggest that cyclin D1 and SPINK1 are reliable markers in differentiating oxyntic gland neoplasms from nonneoplastic oxyntic glands and pyloric gland adenomas. Cyclin D1 is commonly used for immunostaining in many pathology departments, and owing to its higher sensitivity and specificity compared with SPINK1, it is considered the best diagnostic marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypsin Inhibitor, Kazal PancreaticCyclin D1Biomarkers, TumorStomach NeoplasmsHumansFemaleMaleAgedMiddle AgedGene Expression ProfilingAged, 80 and over

Stichwörter der Autor:innen

SPINK1cyclin D1gastric adenocarcinoma of fundic gland typeoxyntic gland neoplasmspatial transcriptome analysis

Substanzen

Trypsin Inhibitor, Kazal PancreaticSPINK1 protein, humanCyclin D1Biomarkers, TumorCCND1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: usikut@g.ecc.u-tokyo.ac.jp.

Förderung

  • The University of Tokyo

Zitieren

APA

Shinozaki-Ushiku, A., Koinuma, D., Nakayama, A., Nawa, J., Fujishiro, M., & Ushiku, T. (2025). Diffuse Cyclin D1 and SPINK1 Expression in Gastric Oxyntic Gland Neoplasms: Promising Diagnostic Markers Identified Using Spatial Transcriptome Analysis. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100719

Vancouver

Shinozaki-Ushiku A, Koinuma D, Nakayama A, Nawa J, Fujishiro M, Ushiku T. Diffuse Cyclin D1 and SPINK1 Expression in Gastric Oxyntic Gland Neoplasms: Promising Diagnostic Markers Identified Using Spatial Transcriptome Analysis. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100719

BibTeX
@article{ShinozakiUshiku2025,
  author = {Shinozaki-Ushiku, Aya and Koinuma, Daizo and Nakayama, Atsuhito and Nawa, Junichi and Fujishiro, Mitsuhiro and Ushiku, Tetsuo},
  title = {Diffuse Cyclin D1 and SPINK1 Expression in Gastric Oxyntic Gland Neoplasms: Promising Diagnostic Markers Identified Using Spatial Transcriptome Analysis},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100719}
}
Kostenlos starten →